Literature DB >> 12875809

Models of HCMV latency and reactivation.

Daniel N Streblow1, Jay A Nelson.   

Abstract

Mesh：

Year:  2003        PMID： 12875809     DOI： 10.1016/s0966-842x(03)00149-5

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


× No keyword cloud information.
  17 in total

1.  Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential.

Authors:  Sergey V Smirnov; Ryhor Harbacheuski; Anita Lewis-Antes; Hua Zhu; Pranela Rameshwar; Sergei V Kotenko
Journal:  Virology       Date:  2006-11-17       Impact factor: 3.616

2.  Nuclear localization of tegument-delivered pp71 in human cytomegalovirus-infected cells is facilitated by one or more factors present in terminally differentiated fibroblasts.

Authors:  Rhiannon R Penkert; Robert F Kalejta
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

3.  CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.

Authors:  Christian O Simon; Rafaela Holtappels; Hanna-Mari Tervo; Verena Böhm; Torsten Däubner; Silke A Oehrlein-Karpi; Birgit Kühnapfel; Angélique Renzaho; Dennis Strand; Jürgen Podlech; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

4.  Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus.

Authors:  Mariana Bego; J Maciejewski; S Khaiboullina; G Pari; S St Jeor
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection.

Authors:  Christof K Seckert; Angélique Renzaho; Matthias J Reddehase; Natascha K A Grzimek
Journal:  Med Microbiol Immunol       Date:  2008-03-26       Impact factor: 3.402

6.  Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication.

Authors:  Patrizia Caposio; Michel Dreano; Gianni Garotta; Giorgio Gribaudo; Santo Landolfo
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

7.  Perivascular stromal cells as a potential reservoir of human cytomegalovirus.

Authors:  M A Soland; L R Keyes; R Bayne; J Moon; C D Porada; S St Jeor; G Almeida-Porada
Journal:  Am J Transplant       Date:  2014-03-04       Impact factor: 8.086

Review 8.  Human Cytomegalovirus Host Interactions: EGFR and Host Cell Signaling Is a Point of Convergence Between Viral Infection and Functional Changes in Infected Cells.

Authors:  Byeong-Jae Lee; Chan-Ki Min; Meaghan Hancock; Daniel N Streblow; Patrizia Caposio; Felicia D Goodrum; Andrew D Yurochko
Journal:  Front Microbiol       Date:  2021-05-07       Impact factor: 5.640

9.  VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.

Authors:  Jian-Ming Li; Kasia A Darlak; Lauren Southerland; Mohammad S Hossain; David L Jaye; Cassandra D Josephson; Hilary Rosenthal; Edmund K Waller
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

Review 10.  Amplification of autoimmune disease by infection.

Authors:  David N Posnett; Dmitry Yarilin
Journal:  Arthritis Res Ther       Date:  2005-02-10       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.